Price T Rowe Associates Inc Dexcom Inc Transaction History
Price T Rowe Associates Inc
- $836 Billion
- Q2 2024
A detailed history of Price T Rowe Associates Inc transactions in Dexcom Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 3,449,901 shares of DXCM stock, worth $232 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
3,449,901
Previous 2,947,440
17.05%
Holding current value
$232 Million
Previous $409 Million
4.32%
% of portfolio
0.05%
Previous 0.05%
Shares
15 transactions
Others Institutions Holding DXCM
# of Institutions
1,112Shares Held
365MCall Options Held
4.1MPut Options Held
3.65M-
Vanguard Group Inc Valley Forge, PA46.5MShares$3.13 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.32 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.3MShares$1.1 Billion0.08% of portfolio
-
Baillie Gifford & CO15.3MShares$1.03 Billion1.38% of portfolio
-
Capital Research Global Investors Los Angeles, CA11.9MShares$804 Million0.31% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $26B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...